The Importance of Preconception Counseling and Early Pregnancy Monitoring

 

 Artikel einzeln kaufen Lizenzen und Reprints

ABSTRACT

Preconception counseling plays a key role in preparing for a pregnancy. In couples with a history of recurrent early pregnancy loss, counseling is of particular importance because women are invariably more distressed and require reassurance that everything possible is being done to avoid future pregnancy losses. Because their subsequent pregnancies are more likely to be planned and these patients may be more willing to adopt recommendations that have been offered to them, it becomes more important to identify which investigations and interventions are the most beneficial. Several interventions ranging from genetic testing to lifestyle changes and medications may have a positive effect on the chances of a successful pregnancy. Early pregnancy monitoring and support increases the chance of a live birth and helps to predict potential future pregnancy complications. Recent research suggests that events that occur in the uterine decidua, even before a woman knows she is pregnant, may have a significant impact on fetal growth and the outcome of pregnancy. With this in mind, shifting future research and clinical practice to focus on the periconceptual period and the very early stages of pregnancy should offer significant benefits to the health of both the mother and her infant. The overall aim should be to effectively use every pregnancy as the health-care opportunity of two lifetimes.

REFERENCES

• 1 Freda M C, Moos M K, Curtis M. The history of preconception care: evolving guidelines and standards.  Matern Child Health J. 2006;  10 (5, Suppl) S43-S52
  Google Scholar
• 2 Johnson K, Posner S F, Biermann J et al.. Recommendations to improve preconception health and health care—United States. A report of the CDC/ATSDR Preconception Care Work Group; Select Panel on Preconception Care.  MMWR Recomm Rep. 2006;  55 (RR-60) 1-23
  Google Scholar
• 3 Boulet S L, Parker C, Atrash H. Preconception care in international settings.  Matern Child Health J. 2006;  10 (5, Suppl) S29-S35
  Google Scholar
• 4 American Academy of Pediatrics and American College of Obstetricians and Gynecologists .Guidelines for Perinatal Care. 6th ed. Washington, DC: ACOG; 2007
  Google Scholar
• 5 Clinical Knowledge Summaries (CKS) .Pre-conception—advice and management. NHS. 2007. Available at: http://www.cks.nhs.uk/pre_conception_advice_and_management Accessed May 2011
  Google Scholar
• 6 Posner S F, Johnson K, Parker C, Atrash H, Biermann J. The national summit on preconception care: a summary of concepts and recommendations.  Matern Child Health J. 2006;  10 (5, Suppl) S197-S205
  Google Scholar
• 7 Speidel J J, Harper C C, Shields W C. The potential of long-acting reversible contraception to decrease unintended pregnancy.  Contraception. 2008;  78 (3) 197-200
  Google Scholar
• 8 Jauniaux E, Farquharson R G, Christiansen O B, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage.  Hum Reprod. 2006;  21 (9) 2216-2222
  Google Scholar
• 9 Li T C, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis.  Hum Reprod Update. 2002;  8 (5) 463-481
  Google Scholar
• 10 Guideline G T. 17. The Investigation and Treatment of Couples with Recurrent First Trimester and Second Trimester Miscarriage. London, UK: Royal College of Obstetricians and Gynaecologists; 2011
  Google Scholar
• 11 American College of Obstetricians and Gynecologists . ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995).  Int J Gynaecol Obstet. 2002;  78 (2) 179-190
  Google Scholar
• 12 The Dutch Society of Obstetrics and Gynecology (NVOG) .Guideline Recurrent Miscarriage. Utrecht, The Netherlands: The Dutch Society of Obstetrics and Gynaecology (NVOG); 2007
  Google Scholar
• 13 Franssen M T, Musters A M, van der Veen F et al.. Reproductive outcome after PGD in couples with recurrent miscarriage carrying a structural chromosome abnormality: a systematic review.  Hum Reprod Update. 2011;  17 (4) 467-475
  Google Scholar
• 14 Musters A M, Repping S, Korevaar J C et al.. Pregnancy outcome after preimplantation genetic screening or natural conception in couples with unexplained recurrent miscarriage: a systematic review of the best available evidence.  Fertil Steril. 2011;  95 (6) 2153-2157 2157 e1-e3
  Google Scholar
• 15 Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages.  Fertil Steril. 2005;  83 (2) 393-397 quiz 525-526
  Google Scholar
• 16 Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax?.  Best Pract Res Clin Obstet Gynaecol. 2007;  21 (1) 157-168
  Google Scholar
• 17 Laurino M Y, Bennett R L, Saraiya D S et al.. Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.  J Genet Couns. 2005;  14 (3) 165-181
  Google Scholar
• 18 Collins J, Diedrich K, Franks S ESHRE Capri Workshop Group et al. Genetic aspects of female reproduction.  Hum Reprod Update. 2008;  14 (4) 293-307
  Google Scholar
• 19 Branch D W, Gibson M, Silver R M. Clinical practice. Recurrent miscarriage.  N Engl J Med. 2010;  363 (18) 1740-1747
  Google Scholar
• 20 Carp H JA, Dirnfeld M, Dor J, Grudzinskas J G. ART in recurrent miscarriage: preimplantation genetic diagnosis/screening or surrogacy?.  Hum Reprod. 2004;  19 (7) 1502-1505
  Google Scholar
• 21 Rai R, Regan L. Recurrent miscarriage.  Lancet. 2006;  368 (9535) 601-611
  Google Scholar
• 22 Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage.  Fertil Steril. 2001;  75 (4) 678-682
  Google Scholar
• 23 Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages.  Fertil Steril. 2000;  73 (2) 300-304
  Google Scholar
• 24 Rai R S, Regan L, Clifford K et al.. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach.  Hum Reprod. 1995;  10 (8) 2001-2005
  Google Scholar
• 25 Rai R S, Clifford K, Cohen H, Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.  Hum Reprod. 1995;  10 (12) 3301-3304
  Google Scholar
• 26 Grimbizis G F, Camus M, Tarlatzis B C, Bontis J N, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results.  Hum Reprod Update. 2001;  7 (2) 161-174
  Google Scholar
• 27 Saravelos S H, Cocksedge K A, Li T C. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal.  Hum Reprod Update. 2008;  14 (5) 415-429
  Google Scholar
• 28 Homer H A, Li T C, Cooke I D. The septate uterus: a review of management and reproductive outcome.  Fertil Steril. 2000;  73 (1) 1-14
  Google Scholar
• 29 Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage.  Hum Reprod. 1997;  12 (2) 387-389
  Google Scholar
• 30 Brigham S A, Conlon C, Farquharson R G. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage.  Hum Reprod. 1999;  14 (11) 2868-2871
  Google Scholar
• 31 Law K L, Stroud L R, LaGasse L L, Niaura R, Liu J, Lester B M. Smoking during pregnancy and newborn neurobehavior.  Pediatrics. 2003;  111 (6 Pt 1) 1318-1323
  Google Scholar
• 32 Kendrick J S, Merritt R K. Women and smoking: an update for the 1990s.  Am J Obstet Gynecol. 1996;  175 (3 Pt 1) 528-535
  Google Scholar
• 33 Troe E J, Raat H, Jaddoe V WV et al.. Smoking during pregnancy in ethnic populations: the Generation R study.  Nicotine Tob Res. 2008;  10 (8) 1373-1384
  Google Scholar
• 34 Mishra G D, Dobson A J, Schofield M J. Cigarette smoking, menstrual symptoms and miscarriage among young women.  Aust N Z J Public Health. 2000;  24 (4) 413-420
  Google Scholar
• 35 Salihu H M, Sharma P P, Getahun D et al.. Prenatal tobacco use and risk of stillbirth: a case-control and bidirectional case-crossover study.  Nicotine Tob Res. 2008;  10 (1) 159-166
  Google Scholar
• 36 Ekblad M, Gissler M, Lehtonen L, Korkeila J. Prenatal smoking exposure and the risk of psychiatric morbidity into young adulthood.  Arch Gen Psychiatry. 2010;  67 (8) 841-849
  Google Scholar
• 37 Newnham J P, Patterson L, James I, Reid S E. Effects of maternal cigarette smoking on ultrasonic measurements of fetal growth and on Doppler flow velocity waveforms.  Early Hum Dev. 1990;  24 (1) 23-36
  Google Scholar
• 38 Falk L, Nordberg A, Seiger A, Kjaeldgaard A, Hellström-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum.  Neuroscience. 2005;  132 (2) 389-397
  Google Scholar
• 39 Werler M M. Teratogen update: smoking and reproductive outcomes.  Teratology. 1997;  55 (6) 382-388
  Google Scholar
• 40 Lindbohm M L, Sallmén M, Taskinen H. Effects of exposure to environmental tobacco smoke on reproductive health.  Scand J Work Environ Health. 2002;  28 (Suppl 2) 84-96
  Google Scholar
• 41 Roza S J, Verburg B O, Jaddoe V WV et al.. Effects of maternal smoking in pregnancy on prenatal brain development. The Generation R Study.  Eur J Neurosci. 2007;  25 (3) 611-617
  Google Scholar
• 42 Kline J, Levin B, Kinney A, Stein Z, Susser M, Warburton D. Cigarette smoking and spontaneous abortion of known karyotype. Precise data but uncertain inferences.  Am J Epidemiol. 1995;  141 (5) 417-427
  Google Scholar
• 43 Armstrong B G, McDonald A D, Sloan M. Cigarette, alcohol, and coffee consumption and spontaneous abortion.  Am J Public Health. 1992;  82 (1) 85-87
  Google Scholar
• 44 Windham G C, Swan S H, Fenster L. Parental cigarette smoking and the risk of spontaneous abortion.  Am J Epidemiol. 1992;  135 (12) 1394-1403
  Google Scholar
• 45 Ness R B, Grisso J A, Hirschinger N et al.. Cocaine and tobacco use and the risk of spontaneous abortion.  N Engl J Med. 1999;  340 (5) 333-339
  Google Scholar
• 46 Chatenoud L, Parazzini F, di Cintio E et al.. Paternal and maternal smoking habits before conception and during the first trimester: relation to spontaneous abortion.  Ann Epidemiol. 1998;  8 (8) 520-526
  Google Scholar
• 47 George L, Granath F, Johansson A LV, Olander B, Cnattingius S. Risks of repeated miscarriage.  Paediatr Perinat Epidemiol. 2006;  20 (2) 119-126
  Google Scholar
• 48 Nielsen A, Hannibal C G, Lindekilde B E et al.. Maternal smoking predicts the risk of spontaneous abortion.  Acta Obstet Gynecol Scand. 2006;  85 (9) 1057-1065
  Google Scholar
• 49 Windham G C, Behren J, Waller K, Fenster L. Exposure to environmental and mainstream tobacco smoke and risk of spontaneous abortion.  Am J Epidemiol. 1999;  149 (3) 243-247
  Google Scholar
• 50 Anderson K, Norman R J, Middleton P. Preconception lifestyle advice for people with subfertility.  Cochrane Database Syst Rev. 2010;  (4) CD008189
  Google Scholar
• 51 Rasch V. Cigarette, alcohol, and caffeine consumption: risk factors for spontaneous abortion.  Acta Obstet Gynecol Scand. 2003;  82 (2) 182-188
  Google Scholar
• 52 Gardella J R, Hill III J A. Environmental toxins associated with recurrent pregnancy loss.  Semin Reprod Med. 2000;  18 (4) 407-424
  Google Scholar
• 53 Kesmodel U, Wisborg K, Olsen S F, Henriksen T B, Secher N J. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion.  Alcohol Alcohol. 2002;  37 (1) 87-92
  Google Scholar
• 54 Florey C D. EUROMAC. A European concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and child development at 18 months. Methods.  Int J Epidemiol. 1992;  21 (Suppl 1) S38-S39
  Google Scholar
• 55 Harlap S, Shiono P H. Alcohol, smoking, and incidence of spontaneous abortions in the first and second trimester.  Lancet. 1980;  2 (8187) 173-176
  Google Scholar
• 56 Bakker R, Pluimgraaff L E, Steegers E AP et al.. Associations of light and moderate maternal alcohol consumption with fetal growth characteristics in different periods of pregnancy: the Generation R Study.  Int J Epidemiol. 2010;  39 (3) 777-789
  Google Scholar
• 57 Jaddoe V WV, Bakker R, Hofman A et al.. Moderate alcohol consumption during pregnancy and the risk of low birth weight and preterm birth. The Generation R study.  Ann Epidemiol. 2007;  17 (10) 834-840
  Google Scholar
• 58 Parazzini F, Chatenoud L, Di Cintio E et al.. Coffee consumption and risk of hospitalized miscarriage before 12 weeks of gestation.  Hum Reprod. 1998;  13 (8) 2286-2291
  Google Scholar
• 59 Domínguez-Rojas V, de Juanes-Pardo J R, Astasio-Arbiza P, Ortega-Molina P, Gordillo-Florencio E. Spontaneous abortion in a hospital population: are tobacco and coffee intake risk factors?.  Eur J Epidemiol. 1994;  10 (6) 665-668
  Google Scholar
• 60 Bech B H, Nohr E A, Vaeth M, Henriksen T B, Olsen J. Coffee and fetal death: a cohort study with prospective data.  Am J Epidemiol. 2005;  162 (10) 983-990
  Google Scholar
• 61 Tolstrup J S, Kjaer S K, Munk C et al.. Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion?.  Hum Reprod. 2003;  18 (12) 2704-2710
  Google Scholar
• 62 Matijasevich A, Barros F C, Santos I S, Yemini A. Maternal caffeine consumption and fetal death: a case-control study in Uruguay.  Paediatr Perinat Epidemiol. 2006;  20 (2) 100-109
  Google Scholar
• 63 Infante-Rivard C, Fernández A, Gauthier R, David M, Rivard G E. Fetal loss associated with caffeine intake before and during pregnancy.  JAMA. 1993;  270 (24) 2940-2943
  Google Scholar
• 64 Weng X, Odouli R, Li D K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study.  Am J Obstet Gynecol. 2008;  198 (3) e1-e8
  Google Scholar
• 65 de Maeyer J, Schepens P J, Jorens P G, Verstraete R. Exposure to pentachlorophenol as a possible cause of miscarriages.  Br J Obstet Gynaecol. 1995;  102 (12) 1010-1011
  Google Scholar
• 66 Li D K, Odouli R, Wi S et al.. A population-based prospective cohort study of personal exposure to magnetic fields during pregnancy and the risk of miscarriage.  Epidemiology. 2002;  13 (1) 9-20
  Google Scholar
• 67 Li D K, Janevic T, Odouli R, Liu L. Hot tub use during pregnancy and the risk of miscarriage.  Am J Epidemiol. 2003;  158 (10) 931-937
  Google Scholar
• 68 Brandt L PA, Nielsen C V. Job stress and adverse outcome of pregnancy: a causal link or recall bias?.  Am J Epidemiol. 1992;  135 (3) 302-311
  Google Scholar
• 69 Florack E IM, Zielhuis G A, Pellegrino J E, Rolland R. Occupational physical activity and the occurrence of spontaneous abortion.  Int J Epidemiol. 1993;  22 (5) 878-884
  Google Scholar
• 70 McDonald A D, McDonald J C, Armstrong B et al.. Fetal death and work in pregnancy.  Br J Ind Med. 1988;  45 (3) 148-157
  Google Scholar
• 71 Aleman A, Althabe F, Belizán J, Bergel E. Bed rest during pregnancy for preventing miscarriage.  Cochrane Database Syst Rev. 2005;  (2) CD003576
  Google Scholar
• 72 World Health Organisation .United Kingdom: health profile. World Health Organisation (WHO); 2008. Available at: http://www.who.int/gho/countries/gbr.pdf Accessed May 2011
  Google Scholar
• 73 World Health Organisation .United States: health profile. World Health Organisation (WHO); 2008. Available at: http://www.who.int/gho/countries/usa.pdf Accessed May 2011
  Google Scholar
• 74 Metwally M, Ong K J, Ledger W L, Li T C. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence.  Fertil Steril. 2008;  90 (3) 714-726
  Google Scholar
• 75 Sebire N J, Jolly M, Harris J P et al.. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London.  Int J Obes Relat Metab Disord. 2001;  25 (8) 1175-1182
  Google Scholar
• 76 Metwally M, Tuckerman E M, Laird S M, Ledger W L, Li T C. Impact of high body mass index on endometrial morphology and function in the peri-implantation period in women with recurrent miscarriage.  Reprod Biomed Online. 2007;  14 (3) 328-334
  Google Scholar
• 77 Cocksedge K A, Li T C, Saravelos S H, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage.  Reprod Biomed Online. 2008;  17 (1) 151-160
  Google Scholar
• 78 Veleva Z, Tiitinen A, Vilska S et al.. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET.  Hum Reprod. 2008;  23 (4) 878-884
  Google Scholar
• 79 Lashen H, Fear K, Sturdee D W. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study.  Hum Reprod. 2004;  19 (7) 1644-1646
  Google Scholar
• 80 Fedorcsák P, Storeng R, Dale P O, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI.  Acta Obstet Gynecol Scand. 2000;  79 (1) 43-48
  Google Scholar
• 81 Bellver J, Rossal L P, Bosch E et al.. Obesity and the risk of spontaneous abortion after oocyte donation.  Fertil Steril. 2003;  79 (5) 1136-1140
  Google Scholar
• 82 Metwally M, Saravelos S H, Ledger W L, Li T C. Body mass index and risk of miscarriage in women with recurrent miscarriage.  Fertil Steril. 2010;  94 (1) 290-295
  Google Scholar
• 83 Helgstrand S, Andersen A MN. Maternal underweight and the risk of spontaneous abortion.  Acta Obstet Gynecol Scand. 2005;  84 (12) 1197-1201
  Google Scholar
• 84 Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage-results from a UK-population-based case-control study.  BJOG. 2007;  114 (2) 170-186
  Google Scholar
• 85 Word Health Organisation .Report of a WHO technical consultation on birth spacing. World Health Organisation (WHO); 2005. Available at: http://whqlibdoc.who.int/hq/2007/WHO_RHR_07.1_eng.pdf Accessed May 2011
  Google Scholar
• 86 Love E R, Bhattacharya S, Smith N C, Bhattacharya S. Effect of interpregnancy interval on outcomes of pregnancy after miscarriage: retrospective analysis of hospital episode statistics in Scotland.  BMJ. 2010;  341 c3967-
  Google Scholar
• 87 Christiansen O B, Andersen A M, Bosch E et al.. Evidence-based investigations and treatments of recurrent pregnancy loss.  Fertil Steril. 2005;  83 (4) 821-839
  Google Scholar
• 88 Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies).  BMJ. 1997;  314 (7076) 253-257
  Google Scholar
• 89 Backos M, Rai R, Baxter N, Chilcott I T, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.  Br J Obstet Gynaecol. 1999;  106 (2) 102-107
  Google Scholar
• 90 Empson M, Lassere M, Craig J C, Scott J R. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.  Obstet Gynecol. 2002;  99 (1) 135-144
  Google Scholar
• 91 Mak I YH, Brosens J J, Christian M et al.. Regulated expression of signal transducer and activator of transcription, Stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro.  J Clin Endocrinol Metab. 2002;  87 (6) 2581-2588
  Google Scholar
• 92 Bose P, Black S, Kadyrov M et al.. Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure.  Am J Obstet Gynecol. 2005;  192 (1) 23-30
  Google Scholar
• 93 Di Simone N, Castellani R, Caliandro D, Caruso A. Antiphospholid antibodies regulate the expression of trophoblast cell adhesion molecules.  Fertil Steril. 2002;  77 (4) 805-811
  Google Scholar
• 94 Sebire N J, Backos M, Gaddal S, Goldin R D, Regan L. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients.  Obstet Gynecol. 2003;  101 (2) 258-263
  Google Scholar
• 95 Bose P, Black S, Kadyrov M et al.. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro.  Am J Obstet Gynecol. 2004;  191 (6) 2125-2131
  Google Scholar
• 96 Dolitzky M, Inbal A, Segal Y, Weiss A, Brenner B, Carp H. A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages.  Fertil Steril. 2006;  86 (2) 362-366
  Google Scholar
• 97 Badawy A M, Khiary M, Sherif L S, Hassan M, Ragab A, Abdelall I. Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology.  J Obstet Gynaecol. 2008;  28 (3) 280-284
  Google Scholar
• 98 Mantha S, Bauer K A, Zwicker J I. Low molecular weight heparin to achieve live birth following unexplained pregnancy loss: a systematic review.  J Thromb Haemost. 2010;  8 (2) 263-268
  Google Scholar
• 99 Kaandorp S, Nisio M, Goddijn M, Middeldorp S. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.  Cochrane Database Syst Rev. 2009;  (1) CD004734-
  Google Scholar
• 100 Kaandorp S P, Goddijn M, Post J A et al.. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage.  N Engl J Med. 2010;  362 (17) 1586-1596
  Google Scholar
• 101 Li D K, Liu L Y, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study.  BMJ. 2003;  327 (7411) 368-371
  Google Scholar
• 102 Nielsen G L, Skriver M V, Pedersen L, Sørensen H T. Danish group reanalyses miscarriage in NSAID users.  BMJ. 2004;  328 (7431) 109
  Google Scholar
• 103 George L, Mills J L, Johansson A LV et al.. Plasma foliate levels and risk of spontaneous abortion.  JAMA. 2002;  288 (15) 1867-1873
  Google Scholar
• 104 Timmermans S, Jaddoe V W, Hofman A, Theunissen R P, Steegers E A. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R study.  Br J Nutr. 2009;  102 (5) 777-785
  Google Scholar
• 105 Mook-Kanamori D O, Steegers E AP, Eilers P H, Raat H, Hofman A, Jaddoe V W. Risk factors and outcomes associated with first-trimester fetal growth restriction.  JAMA. 2010;  303 (6) 527-534
  Google Scholar
• 106 George A, Shamim S, Johnson M et al.. Periodontal treatment during pregnancy and birth outcomes: a metaanalysis of randomised trials.  Int J Evid-Based Healthcare. 2011;  9 (2) 122-147
  Google Scholar
• 107 Polyzos N P, Polyzos I P, Mauri D et al.. Effect of periodontal disease treatment during pregnancy on preterm birth incidence: a metaanalysis of randomized trials.  Am J Obstet Gynecol. 2009;  200 (3) 225-232
  Google Scholar
• 108 Moore S, Ide M, Coward P Y et al.. A prospective study to investigate the relationship between periodontal disease and adverse pregnancy outcome.  Br Dent J. 2004;  197 (5) 251-258 discussion 247
  Google Scholar
• 109 Farrell S, Ide M, Wilson R F. The relationship between maternal periodontitis, adverse pregnancy outcome and miscarriage in never smokers.  J Clin Periodontol. 2006;  33 (2) 115-120
  Google Scholar
• 110 Uppal A, Uppal S, Pinto A et al.. The effectiveness of periodontal disease treatment during pregnancy in reducing the risk of experiencing preterm birth and low birth weight: a meta-analysis.  J Am Dent Assoc. 2010;  141 (12) 1423-1434
  Google Scholar
• 111 Khader Y S, Ta'ani Q. Periodontal diseases and the risk of preterm birth and low birth weight: a meta-analysis.  J Periodontol. 2005;  76 (2) 161-165
  Google Scholar
• 112 Rumbold A, Middleton P, Pan N, Crowther C A. Vitamin supplementation for preventing miscarriage.  Cochrane Database Syst Rev. 2011;  (1) CD004073-
  Google Scholar
• 113 Shah P S, Ohlsson A. Knowledge Synthesis Group on Determinants of Low Birth Weight and Preterm Births . Effects of prenatal multimicronutrient supplementation on pregnancy outcomes: a meta-analysis.  CMAJ. 2009;  180 (12) E99-E108
  Google Scholar
• 114 van Eijsden M, Hornstra G, van der Wal M F, Vrijkotte T G, Bonsel G J. Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study.  Am J Clin Nutr. 2008;  87 (4) 887-895
  Google Scholar
• 115 Porter T F, LaCoursiere Y, Scott J R. Immunotherapy for recurrent miscarriage.  Cochrane Database Syst Rev. 2006;  (2) CD000112
  Google Scholar
• 116 Haas D M, Ramsey P S. Progestogen for preventing miscarriage.  Cochrane Database Syst Rev. 2008;  (2) CD003511
  Google Scholar
• 117 Scott J R, Pattison N. Human chorionic gonadotrophin for recurrent miscarriage.  Cochrane Database Syst Rev. 2000;  (2) CD000101
  Google Scholar
• 118 Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion.  Am J Obstet Gynecol. 1984;  148 (2) 140-146
  Google Scholar
• 119 Liddell H S, Pattison N S, Zanderigo A. Recurrent miscarriage-outcome after supportive care in early pregnancy.  Aust N Z J Obstet Gynaecol. 1991;  31 (4) 320-322
  Google Scholar
• 120 Jauniaux E, Jurkovic D, Henriet Y, Rodesch F, Hustin J. Development of the secondary human yolk sac: correlation of sonographic and anatomical features.  Hum Reprod. 1991;  6 (8) 1160-1166
  Google Scholar
• 121 Dickey R P, Gasser R F, Olar T T et al.. Risk of recurrent abortion after appearance of a chorionic sac or heart rate on vaginal ultrasound.  Lancet. 1994;  344 (8934) 1442-1443
  Google Scholar
• 122 Dickey R P, Gasser R F, Olar T T et al.. The relationship of initial embryo crown—rump length to pregnancy outcome and abortus karyotype based on new growth curves for the 2-31 mm embryo.  Hum Reprod. 1994;  9 (2) 366-373
  Google Scholar
• 123 Stampone C, Nicotra M, Muttinelli C, Cosmi E V. Transvaginal sonography of the yolk sac in normal and abnormal pregnancy.  J Clin Ultrasound. 1996;  24 (1) 3-9
  Google Scholar
• 124 Makrydimas G, Sebire N J, Lolis D, Vlassis N, Nicolaides K H. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation.  Ultrasound Obstet Gynecol. 2003;  22 (4) 368-372
  Google Scholar
• 125 Papaioannou G I, Syngelaki A, Maiz N, Ross J A, Nicolaides K H. Ultrasonographic prediction of early miscarriage.  Hum Reprod. 2011;  26 (7) 1685-1692
  Google Scholar
• 126 Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review.  BJOG. 2010;  117 (3) 245-257
  Google Scholar
• 127 Smith G C, Smith M F, Nay M B, Fleming J E. First trimester growth and the risk of low birth weight.  N Engl J Med. 1998;  339 (25) 1817-1822
  Google Scholar
• 128 Bukowski R, Smith G C, Malone F D FASTER Research Consortium et al. Fetal growth in early pregnancy and risk of delivering low birth weight infant: prospective cohort study.  BMJ. 2007;  334 (7598) 836-
  Google Scholar
• 129 Pedersen N G, Figueras F, Tabor A, Gardosi J. Early fetal size and growth as predictors of adverse outcome.  Obstet Gynecol. 2008;  112 (4) 765-771
  Google Scholar
• 130 Smith G CS. First-trimester determination of complications of late pregnancy.  JAMA. 2010;  303 (6) 561-562
  Google Scholar
• 131 Law L W, Leung T Y, Sahota D S, Chan L W, Fung T Y, Lau T K. Which ultrasound or biochemical markers are independent predictors of small-for-gestational age?.  Ultrasound Obstet Gynecol. 2009;  34 (3) 283-287
  Google Scholar
• 132 Plasencia W, Maiz N, Poon L, Yu C, Nicolaides K H. Uterine artery Doppler at 11þ0 to 13þ6 weeks and 21þ0 to 24þ6 weeks in the prediction of pre-eclampsia.  Ultrasound Obstet Gynecol. 2008;  32 (2) 138-146
  Google Scholar
• 133 Poon L CY, Stratieva V, Piras S, Piri S, Nicolaides K H. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.  Prenat Diagn. 2010;  30 (3) 216-223
  Google Scholar
• 134 Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides K H. Uterine artery Doppler at 11þ0 to 13þ6 weeks in the prediction of pre-eclampsia.  Ultrasound Obstet Gynecol. 2007;  30 (5) 742-749
  Google Scholar
• 135 Leunissen R W, Kerkhof G F, Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood.  JAMA. 2009;  301 (21) 2234-2242
  Google Scholar
• 136 Ekelund U, Ong K K, Linné Y et al.. Association of weight gain in infancy and early childhood with metabolic risk in young adults.  J Clin Endocrinol Metab. 2007;  92 (1) 98-103
  Google Scholar
• 137 Ekelund U, Ong K, Linné Y et al.. Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES).  Am J Clin Nutr. 2006;  83 (2) 324-330
  Google Scholar
• 138 Fagerberg B, Bondjers L, Nilsson P. Low birth weight in combination with catch-up growth predicts the occurrence of the metabolic syndrome in men at late middle age: the Atherosclerosis and Insulin Resistance study.  J Intern Med. 2004;  256 (3) 254-259
  Google Scholar
• 139 Ramadhani M K, Grobbee D E, Bots M L et al.. Lower birth weight predicts metabolic syndrome in young adults: the Atherosclerosis Risk in Young Adults (ARYA) study.  Atherosclerosis. 2006;  184 (1) 21-27
  Google Scholar
• 140 Vos L E, Oren A, Bots M L, Gorissen W H, Grobbee D E, Uiterwaal C S. Birth size and coronary heart disease risk score in young adulthood. The Atherosclerosis Risk in Young Adults (ARYA) study.  Eur J Epidemiol. 2006;  21 (1) 33-38
  Google Scholar
• 141 Geelhoed J JM, Verburg B O, Nauta J et al.. Tracking and determinants of kidney size from fetal life until the age of 2 years: the Generation R study.  Am J Kidney Dis. 2009;  53 (2) 248-258
  Google Scholar
• 142 Poon L C, Akolekar R, Lachmann R, Beta J, Nicolaides K H. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11-13 weeks.  Ultrasound Obstet Gynecol. 2010;  35 (6) 662-670
  Google Scholar
• 143 Goetzinger K R, Singla A, Gerkowicz S, Dicke J M, Gray D L, Odibo A O. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders.  Am J Obstet Gynecol. 2009;  201 (4) 412; e1-e6
  Google Scholar
• 144 Goetzinger K R, Singla A, Gerkowicz S, Dicke J M, Gray D L, Odibo A O. Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free b-hCG.  Prenat Diagn. 2010;  30 (12-13) 1138-1142
  Google Scholar
• 145 Cusick W, Rodis J F, Vintzileos A M, Albini S M, McMahon M, Campbell W A. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.  J Reprod Med. 1996;  41 (5) 327-332
  Google Scholar
• 146 Williams M A, Hickok D E, Zingheim R W, Mittendorf R, Kimelman J, Mahony B S. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.  Obstet Gynecol. 1992;  80 (5) 745-749
  Google Scholar
• 147 Chandra S, Scott H, Dodds L, Watts C, Blight C, Van Den Hof M. Unexplained elevated maternal serum alphafetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.  Am J Obstet Gynecol. 2003;  189 (3) 775-781
  Google Scholar
• 148 Spencer K, Cowans N J, Chefetz I, Tal J, Meiri H. First trimester maternal serum PP-13, PAPP-A and secondtrimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.  Ultrasound Obstet Gynecol. 2007;  29 (2) 128-134
  Google Scholar
• 149 Odibo A O, Zhong Y, Longtine M et al.. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.  Placenta. 2011;  32 (4) 333-338
  Google Scholar
• 150 Pilalis A, Souka A P, Antsaklis P et al.. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation.  Ultrasound Obstet Gynecol. 2007;  29 (2) 135-140
  Google Scholar
• 151 Nicolaides K H, Bindra R, Turan O M et al.. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound.  Ultrasound Obstet Gynecol. 2006;  27 (1) 13-17
  Google Scholar
• 152 Venkat-Raman N, Backos M, Teoh T G, Lo W TS, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome.  Obstet Gynecol. 2001;  98 (2) 235-242
  Google Scholar
• 153 Smith G CS. First trimester origins of fetal growth impairment.  Semin Perinatol. 2004;  28 (1) 41-50
  Google Scholar
• 154 Eckert J P, Fleming T P. SAC review: The effect of nutrition and environment on the preimplantation embryo.  Obstetrician Gynaecol. 2011;  13 (1) 43-48
  Google Scholar
• 155 Kwong W Y, Wild A E, Roberts P, Willis A C, Fleming T P. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension.  Development. 2000;  127 (19) 4195-4202
  Google Scholar
• 156 Bloomfield F H, Oliver M H, Hawkins P et al.. A periconceptional nutritional origin for noninfectious preterm birth.  Science. 2003;  300 (5619) 606
  Google Scholar
• 157 Watkins A J, Wilkins A, Cunningham C et al.. Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring.  J Physiol. 2008;  586 (8) 2231-2244
  Google Scholar
• 158 Sinclair K D, Allegrucci C, Singh R et al.. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status.  Proc Natl Acad Sci U S A. 2007;  104 (49) 19351-19356
  Google Scholar
• 159 Watkins A J, Lucas E S, Torrens C et al.. Maternal low protein diet during mouse pre-implantation development induces vascular dysfunction and altered renin-angiotensinsystem homeostasis in the offspring.  Br J Nutr. 2010;  103 (12) 1762-1770
  Google Scholar
• 160 Woods L L, Ingelfinger J R, Nyengaard J R, Rasch R. Maternal protein restriction suppresses the newborn reninangiotensin system and programs adult hypertension in rats.  Pediatr Res. 2001;  49 (4) 460-467
  Google Scholar
• 161 Teklenburg G, Salker M, Molokhia M et al.. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation.  PLoS ONE. 2010;  5 (4) e10258
  Google Scholar
• 162 Salker M, Teklenburg G, Molokhia M et al.. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss.  PLoS ONE. 2010;  5 (4) e10287-
  Google Scholar
• 163 Teklenburg G, Salker M, Heijnen C, Macklon N S, Brosens J J. The molecular basis of recurrent pregnancy loss: impaired natural embryo selection.  Mol Hum Reprod. 2010;  16 (12) 886-895
  Google Scholar
• 164 Williams D. Pregnancy: a stress test for life.  Curr Opin Obstet Gynecol. 2003;  15 (6) 465-471
  Google Scholar

Lesley ReganM.B.B.S. M.D. F.R.C.O.G. 

Department of Obstetrics and Gynaecology, St. Mary's Campus, Imperial College London

Mint Wing, South Wharf Road, London W2 1PG, UK

eMail: l.regan@imperial.ac.uk